Castrate-Resistant Prostate Cancer (CRPC) can be defined as a disease progression even after the administration of androgen depletion therapy.
Castrate-Resistant Prostate Cancer Market: Introduction
- Castrate-Resistant Prostate Cancer (CRPC) can be defined as a disease progression even after the administration of androgen depletion therapy. It may present itself as either a continuous rise in serum prostate specific antigens (PSA) levels or as the progression of the pre-existing disease, or as the appearance of new metastases.
- Prognosis of castrate-resistant prostate cancer is associated with a wide range of factors, including presence of bone pain, performance status, serum alkaline phosphatase levels, and extent of disease on bone scan
- In over 90% of men with CRPC, bone metastases is known to occur, which leads to significant morbidity, pathologic fractures, bone marrow failure, and spinal cord compression
Read Report Overview - https://www.transparencymarketresearch.com/castrateresistant-prostate-cancer-market.html
Key Drivers and Restraints of Global Castrate-Resistant Prostate Cancer Market
- Incidence of CRPC has been growing globally owing to a rise in the prevalence of prostate cancer, which develops into CRPC after a few years of diagnosis. Prostate cancer is considered to be a leading cause of death in the U.S. According to American Cancer Society, over 191,930 new cases of prostate cancer are anticipated to be recorded in 2020.
- Strong focus on the development of pipeline, evolving treatment patterns of CRPC, growing awareness among people, and increase in government focus on enhancing treatment options are projected to fuel the market during the forecast period
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=80297
- Hormonal therapy is considered to a highly preferred mode of treatment owing to the launch of newer hormonal therapies and presence of a range of approved drugs. Additionally, increase in development of innovative medications to address the unmet needs further boost the market.
- However, lack of standard treatment sequence and variable choice of treatments that depend on patient characteristics and physician preference are likely to hamper the market during the forecast period
Request for Analysis of COVID-19 Impact on Castrate-Resistant Prostate Cancer Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=80297
North America to Lead Global Castrate-Resistant Prostate Cancer Market
- In terms of region, the global castrate-resistant prostate cancer market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- North America dominated the global castrate-resistant prostate cancer market in 2019, owing to strong presence of leading market players, increase in investments on research & development, and surge in prevalence of prostate cancer in the region. Furthermore, a rise in the demand for early diagnosis, growing awareness among people, and government initiatives further propel the market in the region.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=80297
- Europe followed North America in terms of share of the global castrate-resistant prostate cancer market in 2019. The market in Asia Pacific is projected to expand at a rapid pace, followed by Latin America and Middle East & Africa. Rise in focus of governments of countries in Asia on enhancing healthcare facilities, increase in focus of market players on Asia Pacific to leverage growth opportunities, and an increase in patient pool boost the castrate-resistant prostate cancer market in Asia Pacific.
Pre Book Castrate-Resistant Prostate Cancer Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=80297<ype=S
Key Players Operating in Global Castrate-Resistant Prostate Cancer Market
Major market players are focused on expanding their presence in the castrate-resistant prostate cancer market primarily by adopting inorganic growth strategies.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453